Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Dare Bioscience, Inc. (DARE) had Debt to Equity Ratio of 0.53 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.03M |
|
$-13.40M |
|
$0.30M |
|
$0.73M |
|
$14.58M |
|
$-13.55M |
|
$0.15M |
|
$-13.40M |
|
$-13.40M |
|
$-13.40M |
|
$-13.40M |
|
$-13.40M |
|
$-13.40M |
|
$-13.55M |
|
$-11.92M |
|
11.18M |
|
11.18M |
|
$-1.20 |
|
$-1.20 |
|
| Balance Sheet Financials | |
$27.06M |
|
$1.56M |
|
$5.41M |
|
$32.47M |
|
$23.69M |
|
-- |
|
$5.95M |
|
$29.63M |
|
$2.84M |
|
$2.84M |
|
$2.84M |
|
14.50M |
|
| Cash Flow Statement Financials | |
$-9.89M |
|
$-0.39M |
|
$19.28M |
|
$16.00M |
|
$25.01M |
|
$9.01M |
|
$1.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.14 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.53 |
71.29% |
|
-1315.51% |
|
-1315.51% |
|
-1156.86% |
|
-1300.66% |
|
-1300.66% |
|
$-10.27M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-471.37% |
|
-471.37% |
|
-41.26% |
|
-471.37% |
|
$0.20 |
|
$-0.92 |
|
$-0.88 |
|